comparemela.com

Latest Breaking News On - Vita 34 ag stock exchange - Page 1 : comparemela.com

Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment

EQS-News: Vita 34 AG / Key word: Quarter Results Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment 31.05.2023 / 08:00. | May 31, 2023

Ingo middelmenneTarcidomgen kimleucelJakub baranGerman federal statistical officeGene therapyManagement boardVita 34 ag stock exchangePress releaseNvironment v3v de000a0bl849

Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate

EQS-News: Vita 34 AG / Key word: Study Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate 12.05.2023 / 09:10 CET/CEST The issuer is solely responsible for. | May 12, 2023

Ingo middelmenneAnna jakubowskiGrzegorz basakTarcidomgen kimleucelJakub baranUniversity hospital of warsaw medicalMarket researchDepartment of hematologyClinical trialGene therapyManagement boardInternal medicineUniversity hospitalWarsaw medicalChief scientific officerAllied market research

VITA 34 : Annual Report 2022 | MarketScreener

ANNUAL REPORT 2022 Vita 34Annual Report 2022 . | April 30, 2023

Vita 34 ag stock exchangePress releaseEport v3v de000a0bl849

Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects

EQS-News: Vita 34 AG / Key word: Annual Results Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects 30.04.2023 / 12:00. | April 30, 2023

Ingo middelmenneDevelopment of vitaGerman federal statistical officeManagement boardVita 34 ag stock exchangePress releaseFfects v3v de000a0bl849

Vita 34 AG publishes outlook for the 2023 financial year

EQS-Ad-hoc: Vita 34 AG / Key word: Forecast Vita 34 AG publishes outlook for the 2023 financial year 25-Apr-2023 / 18:43 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of. | April 25, 2023

Ingo middelmenneManagement boardAnnual reportVita 34 ag stock exchangePress releaseAr v3v de000a0bl849

vimarsana © 2020. All Rights Reserved.